Assessment of HER2 Protein Overexpression in Primary Ovarian Carcinomas: A Comparison of Two Different Scoring Systems

被引：0
|
作者：
Vasconcellos, Caio [1 ]
Bovolim, Graziele [2 ]
Quintao, Joao Henrique [2 ]
Goncalves, Bruna [1 ]
Baiocchi, Glauco [2 ]
De Brot, Louise [3 ]
机构：
[1] AC Camargo Canc Ctr, Sao Paulo, Brazil
[2] AC Camargo Canc Ctr, Inst Anat Patol, Sao Paulo, Brazil
[3] AC Camargo Canc Ctr, Sao Paulo, Brazil
来源：
LABORATORY INVESTIGATION | 2025年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.labinv.2024.103328
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1094
引用
收藏
页数：3
相关论文
共 50 条
  • [41] HER2 Protein Overexpression and Gene Amplification in Colorectal Adenocarcinomas
    Sun, Y.
    Zhou, L.
    Cao, D.
    MODERN PATHOLOGY, 2013, 26 : 181A - 181A
  • [42] HER2 Protein Overexpression and Gene Amplification in Colorectal Adenocarcinomas
    Sun, Y.
    Zhou, L.
    Cao, D.
    LABORATORY INVESTIGATION, 2013, 93 : 181A - 181A
  • [43] HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features
    He, Lin
    Araj, Ellen
    Peng, Yan
    CURRENT ONCOLOGY, 2021, 28 (03) : 1608 - 1617
  • [44] Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers.
    Li, Bob T.
    Zheng, Tao
    Ni, Ai
    Hellmann, Matthew David
    Jordan, Emmet
    Barron, David
    Smyth, Lillian Mary
    Solit, David B.
    Zehir, Ahmet
    Ross, Dara S.
    Berger, Michael F.
    Ladanyi, Marc
    Rudin, Charles M.
    Kris, Mark G.
    Arcila, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Immunohistochemical Expression of HER2 in Urothelial Carcinoma of the Bladder (UC): Comparison of the Breast Cancer (BC) and Gastric Cancer (GC) HER2 Scoring Systems
    Zhu, B.
    Lin, X.
    Rohan, S.
    Zhong, M.
    Goyal, R.
    Gersbach, E.
    Yang, X.
    LABORATORY INVESTIGATION, 2012, 92 : 257A - 257A
  • [46] Immunohistochemical Expression of HER2 in Urothelial Carcinoma of the Bladder (UC): Comparison of the Breast Cancer (BC) and Gastric Cancer (GC) HER2 Scoring Systems
    Zhu, B.
    Lin, X.
    Rohan, S.
    Zhong, M.
    Goyal, R.
    Gersbach, E.
    Yang, X.
    MODERN PATHOLOGY, 2012, 25 : 257A - 257A
  • [47] HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria
    Sun, Qi
    Li, Qi
    Gao, Fuping
    Wu, Hongyan
    Fu, Yao
    Yang, Jun
    Fan, Xiangshan
    Cui, Xiaobin
    Pu, Xiaohong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 579 - 592
  • [48] HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria
    Qi Sun
    Qi Li
    Fuping Gao
    Hongyan Wu
    Yao Fu
    Jun Yang
    Xiangshan Fan
    Xiaobin Cui
    Xiaohong Pu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 579 - 592
  • [49] HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
    Tuefferd, Marianne
    Couturier, Jerome
    Penault-Llorca, Frederique
    Vincent-Salomon, Anne
    Broet, Philippe
    Guastalla, Jean-Paul
    Allouache, Djelila
    Combe, Martin
    Weber, Beatrice
    Pujade-Lauraine, Eric
    Camilleri-Broet, Sophie
    PLOS ONE, 2007, 2 (11):
  • [50] Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
    Robbins, Charles J.
    Fernandez, Aileen I.
    Han, Gang
    Wong, Serena
    Harigopal, Malini
    Podoll, Mirna
    Singh, Kamaljeet
    Ly, Amy
    Kuba, M. Gabriela
    Wen, Hannah
    Sanders, Mary Ann
    Brock, Jane
    Wei, Shi
    Fadare, Oluwole
    Hanley, Krisztina
    Jorns, Julie
    Snir, Olivia L.
    Yoon, Esther
    Rabe, Kim
    Soong, T. Rinda
    Reisenbichler, Emily S.
    Rimm, David L.
    MODERN PATHOLOGY, 2023, 36 (01)
12345